Literature DB >> 14648149

Muscle structural changes in mitochondrial myopathy relate to genotype.

David B Olsen1, Annika R Langkilde, Mette C Ørngreen, Eigil Rostrup, Marianne Schwartz, John Vissing.   

Abstract

It is well known that morphological changes at the cellular level occur in muscle of patients with mitochondrial myopathy (MM), but changes in muscle structure with fat infiltration and gross variation of muscle fiber size with giant fibers, normally encountered in the muscular dystrophies, have typically not been associated with mitochondrial disease. We investigated gross and microscopic muscle morphology in thigh muscles by muscle biopsy and MRI in 16 patients with MM, and compared findings with those obtained in muscular dystrophy patients and healthy subjects. Changes of muscle architecture, similar to those found in the group of muscular dystrophy patients occurred consistently in patients with a high mutation load for single, largescale deletions of mtDNA, but were absent in all patients with the 3243A-->G mtDNA point mutation. Dystrophic changes of muscle architecture were also present in one MM patient with a unique, sporadic mutation in the mtDNA tRNA(Met) gene. These findings provide evidence that morphological changes in muscle of MM patients are common and may resemble those of muscular dystrophies, but that development of dystrophic-like changes in muscle relate to genotype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14648149     DOI: 10.1007/s00415-003-0206-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  8 in total

Review 1.  Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review.

Authors:  Doris G Leung
Journal:  J Neurol       Date:  2016-11-25       Impact factor: 4.849

2.  Adipogenic potential can be activated during muscle regeneration.

Authors:  Akira Wagatsuma
Journal:  Mol Cell Biochem       Date:  2007-05-09       Impact factor: 3.396

3.  Frequency of dystrophic muscle abnormalities in chronic progressive external ophthalmoplegia: analysis of 86 patients.

Authors:  B H Kiyomoto; C H Tengan; C K Costa; A S Oliveira; B Schmidt; A A Gabbai
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

4.  Thyroid Hormone Receptor α Plays an Essential Role in Male Skeletal Muscle Myoblast Proliferation, Differentiation, and Response to Injury.

Authors:  Anna Milanesi; Jang-Won Lee; Nam-Ho Kim; Yan-Yun Liu; An Yang; Sargis Sedrakyan; Andrew Kahng; Vanessa Cervantes; Nikita Tripuraneni; Sheue-yann Cheng; Laura Perin; Gregory A Brent
Journal:  Endocrinology       Date:  2015-10-09       Impact factor: 4.736

5.  A novel pathogenic m.4412G>A MT-TM mitochondrial DNA variant associated with childhood-onset seizures, myopathy and bilateral basal ganglia changes.

Authors:  Albert Z Lim; Emma L Blakely; Karen Baty; Langping He; Sila Hopton; Gavin Falkous; Kenneth McWilliam; Alison Cozens; Robert McFarland; Robert W Taylor
Journal:  Mitochondrion       Date:  2019-04-22       Impact factor: 4.160

6.  Impaired aerobic capacity and premature fatigue preceding muscle weakness in the skeletal muscle Tfam-knockout mouse model.

Authors:  Benjamin Chatel; Sylvie Ducreux; Zeina Harhous; Nadia Bendridi; Isabelle Varlet; Augustin C Ogier; Monique Bernard; Julien Gondin; Jennifer Rieusset; Håkan Westerblad; David Bendahan; Charlotte Gineste
Journal:  Dis Model Mech       Date:  2021-09-15       Impact factor: 5.758

7.  Endoribonuclease L (RNase L) regulates the myogenic and adipogenic potential of myogenic cells.

Authors:  Tamim Salehzada; Linda Cambier; Nga Vu Thi; Laurent Manchon; Laëtitia Regnier; Catherine Bisbal
Journal:  PLoS One       Date:  2009-10-23       Impact factor: 3.240

8.  Comment on: "Mitochondrial Mechanisms of Neuromuscular Junction Degeneration with Aging. Cells 2020, 9, 197".

Authors:  Allen Herbst; Judd M Aiken; Debbie McKenzie; Jonathan Wanagat
Journal:  Cells       Date:  2020-07-29       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.